Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Clinical trial NCT00808639 · COMPLETED
Trial details
- NCT number
- NCT00808639
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.